ea0068p22 | Abstracts | UKINETS2019
Maynard Alec
, Hill Steven
, Hallam Anna
, Sabbagh Ahmad
, Brown Colleen
, Munir Alia
, Newell-Price John
, Wadsley Jonathan
Introduction: Lutetium-177 Oxodotreotide (Lutathera) is a targeted molecular radiotherapy treatment for advanced, inoperable, progressive neuro-endocrine tumours. We present our experience of Lutathera therapy with particular focus on our experience implementing treatment as a day-case procedure, and assessment of adherence to treatment quality standards surrounding the administration.Aims: To assess safety of Lutathera as a day-case treatment.<p cla...